Steven Landas has held various finance and accounting roles in the biotech industry, including Vice President, Finance & Corporate Controller at Cascadian Therapeutics, Inc. and Director of Accounting at Seattle Genetics. Currently serving as VP Finance and Controller at Lumen Bioscience, Steven Landas has a strong background in financial management and strategic planning. Landas obtained their education from the University of Washington.
Current role